炎症因素和慢性鼻炎:一个总体审查
Stergios T Lialiaris1, Konstantinos Chaidas1, George Fyrmpas1
1Εar, Nose, and Throat Department, University Hospital of Alexandroupolis, School of Medicine, Democritus University of Thrace, Alexandroupolis, GRC.
Cureus
|February 19, 2026
概括
慢性鼻炎 (CRS) 涉及不同的免疫路径,包括1型,2型和3型炎症. 了解这些内型是针对性治疗和有效管理CRS的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 呼吸系统医学 呼吸系统医学
背景情况:
- 慢性鼻炎 (CRS) 是一种普遍的炎症状况,影响鼻通道和鼻.
- CRS呈现异质的临床特征和潜在机制,复杂的分类和治疗.
- 存在两个主要的表型:没有鼻息肉的CRS (CRSsNP) 和带有鼻息肉的CRS (CRSwNP).
研究的目的:
- 审查和综合证据在CRS的独特的炎症路径和免疫模式.
- 探索CRS内型的异质性及其临床影响.
- 评估内型驱动管理和生物疗法的潜力.
主要方法:
- 根据PRISMA指南进行了一次总体审查.
- 在Scopus和PubMed中进行了系统的文献搜索.
- 包括从1968年5月到2025年8月发表的64项研究,并对研究结果进行了定性综合.
主要成果:
- 中枢神经系统炎症涉及不同的T辅助细胞 (Th1,Th2,Th17,Th22) 和T调节细胞 (Treg) 模式.
- 1型炎症 (通常在CRSsNP中) 具有干扰素-,IL-12和中性友的透.
- 2型炎症 (在CRSwNP中很常见) 涉及TSLP,IL-25,IL-33,Th2细胞因子和埃索诺菲尔,影响粘液的产生和上皮的运输.
- 3型 (Th17) 炎症与IL-17,IL-22和宿主对微生物的防御有关.
结论:
- 在CRS的炎症途径是多样化的,可以重叠,影响疾病表型.
- 与阿司匹林加剧的呼吸道疾病和囊性纤维化等并发症会影响CRS内型.
- 以内型为驱动的管理,包括诸如dupilumab之类的生物疗法,是有前途的,但需要进一步精细化,以实现最佳的患者分层和治疗选择.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.9K
Drugs Used in Lower Respiratory Disorders: Overview
1.2K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.2K
Chronic Pharyngitis
12.8K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
12.8K
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Drugs Used in Upper Respiratory Disorders: Overview
719
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
719
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K


